EFI
GILD icon

EHP Funds Inc’s Gilead Sciences GILD Stock Holding History

EHP Funds Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,929
Closed -$658K – 56
2025
Q3 		$658K Buy
+5,929
New +$674K 0.58% 33
2025
Q2 		– Sell
-2,200
Closed -$247K – 44
2025
Q1 		$247K Buy
+2,200
New +$227K 0.19% 34
2024
Q1 		– Sell
-4,700
Closed -$381K – 183
2023
Q4 		$381K Sell
4,700
-10,200
-68% -$794K 0.14% 83
2023
Q3 		$1.12M Buy
14,900
+2,550
+21% +$196K 0.52% 60
2023
Q2 		$952K Buy
12,350
+2,620
+27% +$209K 0.23% 94
2023
Q1 		$807K Buy
+9,730
New +$806K 0.16% 105
2022
Q2 		– Sell
-15,840
Closed -$942K – 434
2022
Q1 		$942K Buy
+15,840
New +$1.01M 0.16% 135

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EHP Funds Inc's GILD Position: Q4 2025 in Review

EHP Funds Inc sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 5,929 shares — an estimated $658K sold.

EHP Funds Inc first reported a position in GILD in Q1 2022 and held it in 7 quarters. The position peaked at $1.12M in Q3 2023. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • EHP Funds Inc reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • EHP Funds Inc sold 5,929 Gilead Sciences shares in Q4 2025, an estimated $658K.
  • EHP Funds Inc first reported a position in Gilead Sciences in Q1 2022 and held it in 7 quarters.
  • EHP Funds Inc's Gilead Sciences position peaked at $1.12M in Q3 2023.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on EHP Funds Inc's 13F filing for Q4 2025, filed 12 Feb 2026.